GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine Read more
Regeneron Announces Start of REGN-COV2 Phase 3 COVID-19 Prevention Trial in Collaboration with NIAID Read more
Sunovion Announces Topline Results from Global Phase 2 Study of SEP-4199 in Patients with Bipolar I Depression Read more
Emergent Signs Five-Year Agreement for Large-Scale Drug Substance Manufacturing for J&J’s Lead COVID-19 Vaccine Candidate Read more